Skip to content

Author

Muhammad Ifham Hanif

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Antidiabetic Agents in the Management of Hepatic Fibrosis in Type 2 Diabetes Mellitus and MASLD/MASH: A Narrative Review

Hepatic fibrosis is a pathological process resulting from chronic liver injury that represents the primary determinant of disease progression toward cirrhosis and cardiovascular complications. In patients with type 2 diabetes mellitus (T2DM), the risk of hepatic fibrosis is significantly elevated, particularly in the c...

Muhammad Ifham Hanif, Triyanta Yuli Pramana, Didik Prasetyo et al. · 0 citations
Review Open access Sep 2026

Modulation of the Gut–Kidney Axis Through Probiotics and Synbiotics in Chronic Kidney Disease: A Narrative Review

Chronic kidney disease (CKD) is associated with increased cardiovascular morbidity and mortality, partly mediated through disruption of the gut–kidney axis. Gut microbiota dysbiosis contributes to the accumulation of uremic toxins, systemic inflammation, and oxidative stress, thereby accelerating CKD progression. This...

A. Susanto, Muhammad Ifham Hanif, M. M. Sholihah · 0 citations
Review Open access Sep 2026

Cryptosporidiosis in Immunocompromised Population: A Review of Neglected Global Disease

Cryptosporidiosis is a diarrheal disease caused by the protozoan Cryptosporidium spp. and is a major cause of morbidity and mortality in children and individuals with weakened immune systems, such as those with HIV/AIDS, cancer, or organ transplant recipients. This infection is transmitted via the fecal-oral route, pri...

M. M. Sholihah, E. Nurhayatun, Dhani Redhono et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.